US Stock MarketDetailed Quotes

Whitehawk Therapeutics (WHWK)

Watchlist
  • 2.790
  • -0.110-3.79%
Close Jan 15 16:00 ET
  • 2.743
  • -0.047-1.67%
Post 17:44 ET
131.49MMarket Cap-4.36P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Whitehawk Therapeutics (WHWK) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
33.48%7.15M
6.69%25.98M
14.43%7.24M
21.03%7.21M
-0.37%6.18M
-8.76%5.35M
60.06%24.35M
21.03%6.33M
Operating revenue
--0
--0
33.48%7.15M
6.69%25.98M
14.43%7.24M
21.03%7.21M
-0.37%6.18M
-8.76%5.35M
60.06%24.35M
21.03%6.33M
Cost of revenue
0
0
16.56%760K
7.65%3.02M
-14.78%790K
15.35%804K
18.60%778K
23.25%652K
110.41%2.81M
317.57%927K
Gross profit
0
0
35.82%6.39M
6.56%22.96M
19.45%6.45M
21.78%6.41M
-2.61%5.4M
-11.93%4.7M
55.21%21.55M
7.87%5.4M
Operating expense
13.75%19.55M
160.90%54.75M
-10.78%21.6M
-6.10%87.78M
9.89%25.4M
-25.65%17.18M
-16.36%20.99M
9.25%24.21M
28.34%93.48M
12.87%23.11M
Selling and administrative expenses
-27.62%5.2M
-24.73%5.94M
20.67%12.82M
-17.51%36.75M
6.82%11.05M
-35.96%7.19M
-32.98%7.89M
-5.24%10.62M
10.88%44.55M
-6.86%10.35M
Research and development costs
43.49%14.35M
272.79%48.81M
-35.35%8.79M
4.29%51.03M
12.37%14.35M
-15.92%10M
-1.67%13.09M
24.07%13.59M
49.80%48.93M
36.26%12.77M
Operating profit
-81.40%-19.55M
-251.32%-54.75M
22.01%-15.22M
9.89%-64.82M
-6.97%-18.95M
39.63%-10.78M
20.27%-15.58M
-15.97%-19.51M
-22.01%-71.93M
-14.49%-17.71M
Net non-operating interest income expense
113.13%1.85M
97.31%1.98M
-35.38%791K
-38.87%3.77M
-53.15%676K
-43.89%868K
-36.40%1M
-23.60%1.22M
184.55%6.17M
-6.90%1.44M
Non-operating interest income
104.19%1.85M
86.52%1.98M
-38.30%791K
-38.67%3.93M
-54.93%676K
-43.55%906K
-35.11%1.06M
-22.77%1.28M
166.89%6.4M
-6.66%1.5M
Non-operating interest expense
--0
--0
--0
-33.33%154K
--0
-34.48%38K
0.00%58K
0.00%58K
0.43%231K
0.00%57K
Other net income (expense)
98.11%-50K
7,850.00%155K
8,744,400.00%87.44M
-264,100.00%-2.64M
0
-2.64M
33.33%-2K
-1K
99.97%-1K
2K
Gain on sale of security
----
-50.00%-3K
----
-300.00%-4K
--0
---1K
33.33%-2K
---1K
---1K
--2K
Special income (charges)
93.29%-177K
--0
--87.44M
---2.64M
--0
---2.64M
--0
--0
--0
--0
-Less：Restructuring and merger&acquisition
--0
----
----
--2.64M
--0
--2.64M
----
----
--0
--0
-Gain on sale of business
---177K
--0
--87.44M
----
----
--0
--0
--0
----
----
Other non- operating income (expenses)
--127K
--158K
----
----
----
----
----
----
----
----
Income before tax
-41.45%-17.75M
-260.80%-52.62M
499.23%73.02M
3.15%-63.69M
-12.32%-18.27M
23.04%-12.55M
18.85%-14.58M
-20.14%-18.29M
-8.68%-65.77M
-16.86%-16.27M
Income tax
0
0
Net income
-41.45%-17.75M
-260.80%-52.62M
499.23%73.02M
3.15%-63.69M
-12.32%-18.27M
23.04%-12.55M
18.85%-14.58M
-20.14%-18.29M
-8.68%-65.77M
-16.93%-16.27M
Net income continuous Operations
-41.45%-17.75M
-260.80%-52.62M
499.23%73.02M
3.15%-63.69M
-12.32%-18.27M
23.04%-12.55M
18.85%-14.58M
-20.14%-18.29M
-8.68%-65.77M
-16.93%-16.27M
Minority interest income
Net income attributable to the parent company
-41.45%-17.75M
-260.80%-52.62M
499.23%73.02M
3.15%-63.69M
-12.32%-18.27M
23.04%-12.55M
18.85%-14.58M
-20.14%-18.29M
-8.68%-65.77M
-16.93%-16.27M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-41.45%-17.75M
-260.80%-52.62M
499.23%73.02M
3.15%-63.69M
-12.32%-18.27M
23.04%-12.55M
18.85%-14.58M
-20.14%-18.29M
-8.68%-65.77M
-16.93%-16.27M
Basic earnings per share
43.48%-0.26
-40.74%-0.76
370.59%1.84
3.28%-2.36
-11.67%-0.67
23.33%-0.46
19.40%-0.54
-19.30%-0.68
9.29%-2.44
-15.38%-0.6
Diluted earnings per share
43.48%-0.26
-40.74%-0.76
369.12%1.83
3.28%-2.36
-11.67%-0.67
23.33%-0.46
19.40%-0.54
-19.30%-0.68
9.29%-2.44
-15.38%-0.6
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0033.48%7.15M6.69%25.98M14.43%7.24M21.03%7.21M-0.37%6.18M-8.76%5.35M60.06%24.35M21.03%6.33M
Operating revenue --0--033.48%7.15M6.69%25.98M14.43%7.24M21.03%7.21M-0.37%6.18M-8.76%5.35M60.06%24.35M21.03%6.33M
Cost of revenue 0016.56%760K7.65%3.02M-14.78%790K15.35%804K18.60%778K23.25%652K110.41%2.81M317.57%927K
Gross profit 0035.82%6.39M6.56%22.96M19.45%6.45M21.78%6.41M-2.61%5.4M-11.93%4.7M55.21%21.55M7.87%5.4M
Operating expense 13.75%19.55M160.90%54.75M-10.78%21.6M-6.10%87.78M9.89%25.4M-25.65%17.18M-16.36%20.99M9.25%24.21M28.34%93.48M12.87%23.11M
Selling and administrative expenses -27.62%5.2M-24.73%5.94M20.67%12.82M-17.51%36.75M6.82%11.05M-35.96%7.19M-32.98%7.89M-5.24%10.62M10.88%44.55M-6.86%10.35M
Research and development costs 43.49%14.35M272.79%48.81M-35.35%8.79M4.29%51.03M12.37%14.35M-15.92%10M-1.67%13.09M24.07%13.59M49.80%48.93M36.26%12.77M
Operating profit -81.40%-19.55M-251.32%-54.75M22.01%-15.22M9.89%-64.82M-6.97%-18.95M39.63%-10.78M20.27%-15.58M-15.97%-19.51M-22.01%-71.93M-14.49%-17.71M
Net non-operating interest income expense 113.13%1.85M97.31%1.98M-35.38%791K-38.87%3.77M-53.15%676K-43.89%868K-36.40%1M-23.60%1.22M184.55%6.17M-6.90%1.44M
Non-operating interest income 104.19%1.85M86.52%1.98M-38.30%791K-38.67%3.93M-54.93%676K-43.55%906K-35.11%1.06M-22.77%1.28M166.89%6.4M-6.66%1.5M
Non-operating interest expense --0--0--0-33.33%154K--0-34.48%38K0.00%58K0.00%58K0.43%231K0.00%57K
Other net income (expense) 98.11%-50K7,850.00%155K8,744,400.00%87.44M-264,100.00%-2.64M0-2.64M33.33%-2K-1K99.97%-1K2K
Gain on sale of security -----50.00%-3K-----300.00%-4K--0---1K33.33%-2K---1K---1K--2K
Special income (charges) 93.29%-177K--0--87.44M---2.64M--0---2.64M--0--0--0--0
-Less：Restructuring and merger&acquisition --0----------2.64M--0--2.64M----------0--0
-Gain on sale of business ---177K--0--87.44M----------0--0--0--------
Other non- operating income (expenses) --127K--158K--------------------------------
Income before tax -41.45%-17.75M-260.80%-52.62M499.23%73.02M3.15%-63.69M-12.32%-18.27M23.04%-12.55M18.85%-14.58M-20.14%-18.29M-8.68%-65.77M-16.86%-16.27M
Income tax 00
Net income -41.45%-17.75M-260.80%-52.62M499.23%73.02M3.15%-63.69M-12.32%-18.27M23.04%-12.55M18.85%-14.58M-20.14%-18.29M-8.68%-65.77M-16.93%-16.27M
Net income continuous Operations -41.45%-17.75M-260.80%-52.62M499.23%73.02M3.15%-63.69M-12.32%-18.27M23.04%-12.55M18.85%-14.58M-20.14%-18.29M-8.68%-65.77M-16.93%-16.27M
Minority interest income
Net income attributable to the parent company -41.45%-17.75M-260.80%-52.62M499.23%73.02M3.15%-63.69M-12.32%-18.27M23.04%-12.55M18.85%-14.58M-20.14%-18.29M-8.68%-65.77M-16.93%-16.27M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -41.45%-17.75M-260.80%-52.62M499.23%73.02M3.15%-63.69M-12.32%-18.27M23.04%-12.55M18.85%-14.58M-20.14%-18.29M-8.68%-65.77M-16.93%-16.27M
Basic earnings per share 43.48%-0.26-40.74%-0.76370.59%1.843.28%-2.36-11.67%-0.6723.33%-0.4619.40%-0.54-19.30%-0.689.29%-2.44-15.38%-0.6
Diluted earnings per share 43.48%-0.26-40.74%-0.76369.12%1.833.28%-2.36-11.67%-0.6723.33%-0.4619.40%-0.54-19.30%-0.689.29%-2.44-15.38%-0.6
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -